3 Reasons SGRY is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Surgery Partners, Inc. (NASDAQ: SGRY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $35.00 price target on the stock.
Surgery Partners, Inc. (NASDAQ: SGRY) had its price target lowered by analysts at Macquarie from $34.00 to $33.00. They now have an "outperform" rating on the stock.
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations [Yahoo! Finance]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance [Yahoo! Finance]